ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001041.1|Salinosporamide_1 # 193 # 1290 # 1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGAGGA;rbs_spacer=10bp;gc_cont=0.706	BGC0001041.1|Salinosporamide_1 	193	1290	+	Loose	290	61.2326	golS	32.38	3000504	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGGGCAAGCGGCCGGGCTGGCTGGCGTAACCGTCCGCGCACTGCATCACTACGACGAGATCGGCCTCCTGCGGCCGTCCACGCGGACCGTGGCGGGACACCGGGCCTACTCGGCGGGCGACGTGGAGCGACTGCGGGAGGTGCTCGCGTACCGGAGGCTCGGTTTCGGGCTGCGGGAGATCGCGGACCTGGTCAACGATCCGACCACCGACGCGGTCGCGCACCTGCGTCGGCTGCGTGGGCTGCTGCTGGACCAACGCGACCGCGCCGCCGCCACGGTGACGGCCATTGACCGGGAATTGGAGGCACGGGCAATGGGAGTCAGGACGACGCCAGCGGAACAGTTGAAAGTGTTCGGTGCGCAGTTGTACGACACGATCGGATCCGCCTATCCAACGACGCGGCGTACCGAGCCACGGATCGCCGCCCGGATCTGGGATGCACTGGGAGACGCCCGTACGGTGCTGAACGTTGGGGCTGGCACCGGTTCCTACGAACCTCACGACCGGGAGGTCACGGCGGTGGAGCCCTCGGGGGTCATGCGGGCCCAGCGTCCCGTGGGCGCGGCGCCCTGCGTGGCCGCCGCCGCGGAGAGTCTGCCGTTCGAGGACCAGTCGTTCGACGCCGCGATGGCGGTCAGCACCGTGCATCACTGGCGAGATCCGGTCGCCGGCCTGCGGGAGATGCGGCGGGTCGCGCGTCGCGTGGTGGTGTTCACGTACGACGCTGAGGACACCGGCTGGGGCCAGCGATTCTGGCTCACCCGCGACTACCTACCCGAGTTCGCGGAGCTGCTCGTCAACTGGCCGTCCCTCGCCGACCTGACCCACGCGATCGGAGGACGCGCGGAGCCGGTACTCGTACCGTGGGACTGCGTGGACGGCTTCTTCGAGGCGCACTGGCGCCGGCCCGCGGCGTACCTGGACGAACACGTACGCCGGGCGGTGTCGGTCTGGACCAGAGTGGGGGCGCAGGCGGAACAACGGGCGGTCCGGTCGCTTCGCGAAGACCTGTCATCCGGCCGGTGGGCCGAGCGAAACCGGGACCTCGTCGCCCTCGACACGGCCGAGCTCGGCCTCCGACTGCTCGTGGCATGA	MGQAAGLAGVTVRALHHYDEIGLLRPSTRTVAGHRAYSAGDVERLREVLAYRRLGFGLREIADLVNDPTTDAVAHLRRLRGLLLDQRDRAAATVTAIDRELEARAMGVRTTPAEQLKVFGAQLYDTIGSAYPTTRRTEPRIAARIWDALGDARTVLNVGAGTGSYEPHDREVTAVEPSGVMRAQRPVGAAPCVAAAAESLPFEDQSFDAAMAVSTVHHWRDPVAGLREMRRVARRVVVFTYDAEDTGWGQRFWLTRDYLPEFAELLVNWPSLADLTHAIGGRAEPVLVPWDCVDGFFEAHWRRPAAYLDEHVRRAVSVWTRVGAQAEQRAVRSLREDLSSGRWAERNRDLVALDTAELGLRLLVA	MNIGKAAKASKVSAKMIRYYEQIGLIPAASRTDSGYRAYTQADVNQLHFIRRARDLGFSVAEISDLLNLWNNQSRQSADVKRLAQTHIDELDRRIQNMQHMAQTLKALIHCCAGDALPDCPILHTLGQPDDSEPEARTGAVLRRPRRHGLAKRL	237.01	gnl|BL_ORD_ID|35|hsp_num:0	44			6	321	chloramphenicol
BGC0001041.1|Salinosporamide_3 # 3971 # 4807 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.632	BGC0001041.1|Salinosporamide_3 	3971	4807	+	Loose	500	29.261	APH(3')-IIc	28.99	3002646	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGAATCGGGGTCTGCCGTCCACGTTCTTAACATTTCATTCTTCCTCGTTTGTCGAGTTGTTGAAGGAATACGATCCCACGCTGCTGCCGGCCAAGCGTGCCGCCGAGACGTTCGGCGAGGCTCCGCACGGCACCACCATAGTGGCCGCCACGTTCGCTGGTGGCGTCCTGCTCGCTGGCGACCGTCGTACGACCATGGGGAACCTGATCGCCGGCCGGGACGTGGACAAACTCACGATCACGGACGACTATTCGGCGGTCGGTTTCGCCGGCACGGTGGGCATCTCCATTGACATGACTCGGTTGTTTGTCGTCGAGCTGGAGCATTATGAGAAGATCGAGGGCGTCCCGCTCTCACTGGAGGGCAAGAGCAACCGGCTCGCTGCCATAGTCAAGGGAAACCTCCCCATGGCCAACGCGGGCATGGTTTCTATCCCGCTGTTCATCGGCTACGATCTCGAGGCATCCGATCCTGCGAGGGCCGGCCGGATCGTGTCGTTCGACGCAATCGGCGCCCGCTATGAGGAAAAGTCCGGCTACCAGTCGATCGGCTCGGGCTCCCCCTTCGCTAAATCGTCTCTGAAGAAGCTACACGACCCCGGTTCCGATGATGCGGCTACCCTGAGTGCCCTGATCGAGGCGCTGTACGATGCCGCCGATGATGACTCGGCCACCGGCGGCCCCGACATGGTCCGCCGCATTTTCCCCACGGCCATCCGCATCACGGCCGAGGGCGCCTACCGATACACAGAGGAGGAACTCGCGGCAGTCGCCGACGCCGTCGTCGCCCGGCGTAGTGCCGACGAGCCCGGCGTCCGAAGCTTTACCGCGTCCTGA	MNRGLPSTFLTFHSSSFVELLKEYDPTLLPAKRAAETFGEAPHGTTIVAATFAGGVLLAGDRRTTMGNLIAGRDVDKLTITDDYSAVGFAGTVGISIDMTRLFVVELEHYEKIEGVPLSLEGKSNRLAAIVKGNLPMANAGMVSIPLFIGYDLEASDPARAGRIVSFDAIGARYEEKSGYQSIGSGSPFAKSSLKKLHDPGSDDAATLSALIEALYDAADDDSATGGPDMVRRIFPTAIRITAEGAYRYTEEELAAVADAVVARRSADEPGVRSFTAS	MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFSELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLADALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRATRPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRCVAALFQRYGAVPDERRLAFYRLLDEFF	104.12	gnl|BL_ORD_ID|939|hsp_num:0	1018			84	279	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0001041.1|Salinosporamide_5 # 7014 # 8396 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGGA;rbs_spacer=7bp;gc_cont=0.680	BGC0001041.1|Salinosporamide_5 	7014	8396	-	Loose	660	41.2022	MexS	22.85	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCCAGCTGACCGACGCCGTGCTCAGCAACGCGACGGCGGCAGAGATCGCCGCCGCTCCGCTACCCGAGGAGTACTTCGCCGCCCACCTGCGGGTCGAAGACGCCACGATGTTCGAGGGCGTCGTGGACAAGGACGTCCGCAAGTCGCTGCGGCTCGGTCACGTTCCAATGCCCGAGCTGGCTCCGGACGAGGTCCTCGTCGCGGTGATGGCGAGCGCGGTCAACTACAACACCGTGTGGTCGGCGATGTTCGAGCCGATGTCCAGCTTCCGCTATCTGAAGGGGCTCGCCCGGCAGGGTGGCTGGGCGAAACGGCACGACCAACCCTTCCACGTGGTCGGCTCCGACTGCGCTGGGGTGATCGTGCGCACCGGCTCCGGCGTCCGCCGCTGGGAGATCGGCCAGCACGTCGTGGTGAGCCCGGCGTACGTGGACGACCAGGAGCCCACCACGCACGCCGACGGAATGCTCGGCGGGGACCAGAAGGCGTGGGGTTTCGAGACAAACTTCGGGGCGCTGGCCGAGTTCACGGTGGTCCGGGCCACCCAGCTGATTCCCAAGCCCGCCCACCTCACCTGGGAGGAGGCCGCGAGCGTCCCGCTGTGCGCGGGAACCGCCTACCGGATGCTGGTCAGCGAGCGCGGCGCGAACATGAAGCAGGGAGACGTCGTGCTCGTCTGGGGTGCGGCCGGCGGTCTCGGCGGCTACGCAGTGCAGTATGTGCGTAACGGTGGCGGCATCCCGGTGGCCGTCGTCGGGTCCGAGCGCAAGGCGGAGGCAATGCGCCGACTCGGCTGCGAGGTGATTCTCAACCGGACCGAGATCGGCATCACTGACGAGATCGCCGACGACCCGAAGCAGGTGATCAGAGCCGGCGTGCGGCTCGGCGAAATGATCAACGAACAGGTGGGCCGGGCTCCGGATATCGTCTTCGAGCACATCGGACGGCCCACCTTCGGGATATCGGTGTTCGTCGCACAGCGCGGCGGCACCGTAGTGACGTGCGGCTCGAGCGCCGGGTATCAGCACAGCTTCGACAACCGCTACCTGTGGATGCGCCTCAAACGGATCATCGGCAGCCACATCGCCAACCTCCAAGAGTACTGGGATGCGCACCGCCTGTTCGAACTCGGTCACATCGTGCCGACCATGTCGGCGGTCTATCCGTTGACGGACGTCGCGGCCGCCTGCCGTCTCGTGCAGGCCAACCAGCAGATCGGCAAAATCGCCGTGCGCTGCCTGGCACCCCGCGCCGGGCTCGGGGTGACCAACCCCGAGTTGCGCGAGCGCATCGGCGAGGACCGCCTGAACCCGTGGCGCGGCCTCACCACCGGCTCTGACGGTGCCGAGTTCGGAGGACAGCGTGACGACCCGGCCTAA	MGQLTDAVLSNATAAEIAAAPLPEEYFAAHLRVEDATMFEGVVDKDVRKSLRLGHVPMPELAPDEVLVAVMASAVNYNTVWSAMFEPMSSFRYLKGLARQGGWAKRHDQPFHVVGSDCAGVIVRTGSGVRRWEIGQHVVVSPAYVDDQEPTTHADGMLGGDQKAWGFETNFGALAEFTVVRATQLIPKPAHLTWEEAASVPLCAGTAYRMLVSERGANMKQGDVVLVWGAAGGLGGYAVQYVRNGGGIPVAVVGSERKAEAMRRLGCEVILNRTEIGITDEIADDPKQVIRAGVRLGEMINEQVGRAPDIVFEHIGRPTFGISVFVAQRGGTVVTCGSSAGYQHSFDNRYLWMRLKRIIGSHIANLQEYWDAHRLFELGHIVPTMSAVYPLTDVAAACRLVQANQQIGKIAVRCLAPRAGLGVTNPELRERIGEDRLNPWRGLTTGSDGAEFGGQRDDPA	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	135.69	gnl|BL_ORD_ID|1039|hsp_num:0	1041			45	759	ciprofloxacin; trimethoprim; chloramphenicol
BGC0001041.1|Salinosporamide_6 # 8384 # 9244 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=10bp;gc_cont=0.674	BGC0001041.1|Salinosporamide_6 	8384	9244	-	Loose	600	41.2022	EstT	28.33	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGCCGTTTGCGTTCGCCAACGACATCAGGTTGCACTACGAATTGCATGGCACGGGCGATCCCGTGGTGCTGGTCAGTGGTGCCGGCGTATCCGGGAAATCCTGGCTGATCCATCAGGGGCCGGCACTGCTGGAGAACGGCTACCGGGTCTGCGTCTACGACAGCCGCGGCCAACCACCCAGCGATGAGTGCGTCAGCGGCTTCGTCGTGGAGGATCTGGTAGCCGACCTCGCAGCCCTACTGGAGTTCCTCGACGCTGGCCCGGCCCGCCTCATCGGCACCTCGACGGGTGCCTACGTGGTGCAGGAGCTTGCCCTGCGTCGACCGGAGCTGGTTCGGCAGGCGGTGTTGATGGCCAGCCGGGCCCGTCCCGACGTGTTACGGACACAGCTGGCGCGTGCCGAGATCGAGTTGGGCGAGTCTGGGGTGACGCTGCCGTCCTCGTATCGCGCGGTCGTTCGCGCGCTCCAGATGCTCTCGCCACGATCGATGGACGACGAGTCGTCGATCCGCGACTGGCTGGCCCTGCTCGAGCTCGCCCCGCCCGACGGAGCGGGAGTACGGCATCAGCTCGCTCTCCAACCGATGCCGGACCGCCGCGCCGCCTACGCCGAGATCGCGGTGCCCTGCCACGTCGTGTCGTTCGCGGATGACTTGATCGCGCCGCCCGGGTACGGCGAGGAGCTGGCGGGGTGTATTCCCGGCGCCACCTTCGACTTGGTCGGGGACGCCGGCCACTTCGGCTACCTGGAACGGCCCGAGGAGGTCAACCACATCATCGCCAAACATTTCGCGGGCATCGGCGCCCGCCTCACCGGACACAACCCAGACACCAGGAGGAGTGCGCCATGGGCCAGCTGA	MPFAFANDIRLHYELHGTGDPVVLVSGAGVSGKSWLIHQGPALLENGYRVCVYDSRGQPPSDECVSGFVVEDLVADLAALLEFLDAGPARLIGTSTGAYVVQELALRRPELVRQAVLMASRARPDVLRTQLARAEIELGESGVTLPSSYRAVVRALQMLSPRSMDDESSIRDWLALLELAPPDGAGVRHQLALQPMPDRRAAYAEIAVPCHVVSFADDLIAPPGYGEELAGCIPGATFDLVGDAGHFGYLERPEEVNHIIAKHFAGIGARLTGHNPDTRRSAPWAS	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	93.46	gnl|BL_ORD_ID|4956|hsp_num:0	5948			93	453	tigecycline
BGC0001041.1|Salinosporamide_7 # 9244 # 9459 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.676	BGC0001041.1|Salinosporamide_7 	9244	9459	-	Loose	880	23.8682	arlS	35.71	3000839	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATTGCCAACCCCCTCGATCCGGGCGACGGCACGTGGCTGGTCGTGGTTAACGACGCCGGCCAACACGCGCTGTGGCGGCCCTTTCTGGATATGCCGCCCGGCTGGCGTGTCGTCCTACGCGACGCCGACCACGACGCGGCCCTTGACTACGTCGAGCGCAACTGGACTGCCCTGCAACCCGCGGGCCACAGCGAACCGGGGGCGACGAGGTAA	MIANPLDPGDGTWLVVVNDAGQHALWRPFLDMPPGWRVVLRDADHDAALDYVERNWTALQPAGHSEPGATR	MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF	15.74	gnl|BL_ORD_ID|165|hsp_num:0	182			96	180	ciprofloxacin; acriflavine; norfloxacin
BGC0001041.1|Salinosporamide_8 # 9465 # 10742 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.642	BGC0001041.1|Salinosporamide_8 	9465	10742	-	Loose	900	27.335	msrF	30.0	3005087	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGACCGCCGCGGACACAGGTCGCGTGGGTTCAGGCGAAAGCCAAACGCCGGCCCACACCGTCGACCTAGCCGACCCCGCCACCTTCGCCAATCACGACCTGACCGGTTTCTGGCAACAGCTGCGCGACGAGGAGCCGATCCACTGGAATCCCCCGACAGCCGGACGTCGAGGCTTCTGGGTGGTGTCGCGATACGCAGACATTCTCGACGTCTACCGCGACGACGTCACCTTCACCTCAGAGCGCGGGAATGTGCTCGTGACGTTGCTGGCGGGCGGTGACGCGGGCGCTGGCCGGATGCTGGCGGTCACCGACGGGCCGCGTCACGCGGAGTTGCGCAAGCTGCTGTTGCGGGCATTGGGGCCGCGCGTACTCGCGCCAGTCTGCGCCGCGGTGCGGACCAACACCCGGCAGATGATCCGCGAGGCAGTCACCAAGGGTGAGTGCGACTTCGCGTCCGACATCGCCAGCCGCATTCCGATGATGACGATCTCCAACCTGCTGGGGGTCCCCGACGCGGACCGTGCCTTCCTGCTGAGTCTGACGAAGACGGCGCTGAGCGCCGACGACGAAAGCATCAGCGAGACCGAGTCCGCGATGGCACGCAACGAGATCCTGCTCTACTTCCAAGACCTCATGGAGTTCCGGCGCGACCACCCCGGCGAGGATGTCGTGAGCATGCTGGTGAACAGCAGCATCGACGGAGCGCCCCTTTCGGACGACGACATAGTGCTCAACTGCTACAGCCTGATCATCGGCGGCGACGAAACGAGTCGGCTAACCATGATCGATAGCGTGAATACGCTGGCTGCACACCCCCAGCAGTGGAGGCGACTCAAAGATGGTCAATGCGAGATCGACAAGGCCGTGGACGAGGTACTGCGCTGGGCCTCACCCTCGATGCACTTCGGACGGGTGGCAGCGCGGGACACCATTCTTCATGGAGTGCGGATCCGGGCGGACGACATAGTTACCCTCTGGCATGCCTCCGGCAACCGCGATGAGCGGGTCTTCCATCGGCCGGAGGTGTTCGACCTGGGCCGTACACCCAACCGGCACCTCTCGTTTGGGCACGGGCCTCACTACTGCATCGGTTCCTACCTTGCCAAGGTGGAGATCTCGGAGCTGCTGATCGCTCTGCGGGATCTGACATCGGGTTTTGAGACAACAGGCGAGCCGCAACGGATCCGGTCGAACCTGCTCACTGGCTTCGCCACCATGCCAGTCCGCTTCGTTCCTGATCGTGCAGGGCTCGCTCGCGACGCGCTGGATGGGTGA	MTAADTGRVGSGESQTPAHTVDLADPATFANHDLTGFWQQLRDEEPIHWNPPTAGRRGFWVVSRYADILDVYRDDVTFTSERGNVLVTLLAGGDAGAGRMLAVTDGPRHAELRKLLLRALGPRVLAPVCAAVRTNTRQMIREAVTKGECDFASDIASRIPMMTISNLLGVPDADRAFLLSLTKTALSADDESISETESAMARNEILLYFQDLMEFRRDHPGEDVVSMLVNSSIDGAPLSDDDIVLNCYSLIIGGDETSRLTMIDSVNTLAAHPQQWRRLKDGQCEIDKAVDEVLRWASPSMHFGRVAARDTILHGVRIRADDIVTLWHASGNRDERVFHRPEVFDLGRTPNRHLSFGHGPHYCIGSYLAKVEISELLIALRDLTSGFETTGEPQRIRSNLLTGFATMPVRFVPDRAGLARDALDG	MEQICFELENVEVTFLDKKILEIDRLAVHQFDRIGIVGKNGAGKSTLLKILGGIIKPTRGKVNRYIDYGYFEQVESPKVSMADPRLLGKLNVKVDSNNLSGGELTRLKIAQLFTDYYESLLIDEPTTHLDQDGISFLIDKLKYYYGALVLISHDRNLLDELVTTIWEIDDGMIKVYSGNYSEYLRQKKVEREQQAHDFDLYLKEKNRLEKAAKEKMNKAEKIANSSSMSKKESKAKANRMFESKSKGTSQKSLQRAAKAVEKRIEQLEVVDAPKEIHTIQFHQTHSTPPLHNKFPILGDRLTLQAGDKTLLEETSFQFPLGKTIAITGNNGSGKTTLIHHIIQKGEGITISPKAVIGFYEQMGYQFNEDKTVLSYMKARSDYDESKIRSVLHAMNFNGNDLKKNVRYLSGGEATRLVLCQLFLGRYNILILDEPTNFLDIFCIEALERFIEEYEGTIILISHDKKFVDHVSDTIYKIENKKLNLVN	87.45	gnl|BL_ORD_ID|2804|hsp_num:0	3821			966	1086	erythromycin
BGC0001041.1|Salinosporamide_9 # 10739 # 12532 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=9bp;gc_cont=0.671	BGC0001041.1|Salinosporamide_9 	10739	12532	-	Loose	750	58.9214	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	23.49	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCGAAGCCGTTGAGCGGAACTACGATCCGGGAGACGTCGCCATCATCGGCGCCTCGTGCAGATTCCCTGGCGCACGAAACAAGGAACAGTACTGGGACAACCTTCTCCATGGGCGCGAGGGCGTGACCTTTTACGCCAAGGACGAGATCGAGGTGGACGAGACGCTCATCAACAGTCCGGCGTACGTGCGGGCCACCGGAGCACTGGACGGATACGACGAGTTCGATCCCGCCGTGTTCGGTGTTAGCGATCGAATGGCGGCGGCGATGACTCCCGAGCACCGGGTCTTCCTGGAGGCATCCTGGGAGGTGATGGAGGACGCCAGCTACGACCCCGAGCGGGTCCGCGGCGAGGTGGGCGTCTACGCCTCGACCAACCCGCAGAGCGCGGCCCTCTACAGCTCACCACCGGACTGGGTATCGGCCGGCCCGGAGGTGATGGACCGCAGTAACGCATGGCTACCGGACACGATCACCTCCAACGTCTTGTACTACCTCGGCCTGACCGGTGAGGCGGTCACCGTGACCGCCGTGTGCTCGGGCTTTCACTATGCGGTGCACCTCGCGTGCCAGTCACTTCTCCTAGGCCAGACTGATATGGCGATCGCGGGCGGCGTCATGGTTCGGCTGCCCCAGCGCCGCGGCTATCTGTGGGAGGAGGGTCGAATTCTGTCCCGCGACGGCCACTGCCGCCCCTTTGACGCGAACGGCACCGGATCGGTACTGGCCAGCGGAGTCGCGGTGGTCCTACTCAAGCCACTGCCACAGGCCGTCGCCGACCGCGACCACATCTATGCAACGGTCAAGGGAACGGCCATCAACAACAACGGCATCAGTGCCATGGCGTACGGCCTCGCGCAGCCTGAACGGCTCAGCGCCTGCATCGCCGGTGCGATGCAGGCCGGCGATGTGGCGCCCGAAACGGTGTCCATGTACGAGGCCAATGGGTTCGGCATGCCCATCACGGACTCGCTCGAGGTGCACGCCGCCCATCTGGCGTTCGGGAAGCAGTCCGGCACCTGCTCGATTGGGGCGGTCAAGGGCAATATCGGGCACGCCGGCGTGGTTGCCGGTGGCTCCGGCGCGGTCAAGGCGGCGTTCGCGCTGTACCACCGCAGTCTCCCGCCCACCATCAACCTGACCGAGCTCAACGAAGAAATCGACTTCCCGCGTACTCCGTTCGTCCCGCAACTGGAGCCCGCCGCCTGGCAGCCGGAGTGCGGCATCAGACGGGCCGGCATCACCGCGCTCGGCGGCGGCGGGTACAACGCGCACCTGGTCCTCGAGGAGCCGCCGCGTCCGGTCGAACGGGAGCCCGAGAACCGCCGGCCCCGGATCGTCACGCTGTCGGCGCTCGACGACGCCGCGGTCTCCCGCCAACGCGCGGCCCTGTCCTCCTGGCTCGCTGAGCATTCCGATGCTCGGCTCGACGACATCGCCTATAGCCTCAACCTCGGGCGTAAGGCGCTGCCATCCCGATGGGCGGCCGTCATCAGCACCCGCGACGAACTGCTCGAGGTGCTGTCGGGCGACGGCAAGAGCGGTCGGGTGTCTCGCTTCGGCCAAGAGCGCCGCGCCGACCTGGCGCGTTTTCGGCGCACCGAAGACGGACTCGCTCTCGGCAGCGGGGACGAGATGCGCGACGTTCAGGCGCTGACCGAGCTCGCCGCAGCATGGGTGCAGGGGGAACGCGTGAACTTCGAGGTGTTGCACGCCGACGAACGCAGCCACCGCATTTCGTTGCCCAACTATCCGTTCGCGCGCCGACGGTTCTGGCGCACCGACTGGTGA	MSEAVERNYDPGDVAIIGASCRFPGARNKEQYWDNLLHGREGVTFYAKDEIEVDETLINSPAYVRATGALDGYDEFDPAVFGVSDRMAAAMTPEHRVFLEASWEVMEDASYDPERVRGEVGVYASTNPQSAALYSSPPDWVSAGPEVMDRSNAWLPDTITSNVLYYLGLTGEAVTVTAVCSGFHYAVHLACQSLLLGQTDMAIAGGVMVRLPQRRGYLWEEGRILSRDGHCRPFDANGTGSVLASGVAVVLLKPLPQAVADRDHIYATVKGTAINNNGISAMAYGLAQPERLSACIAGAMQAGDVAPETVSMYEANGFGMPITDSLEVHAAHLAFGKQSGTCSIGAVKGNIGHAGVVAGGSGAVKAAFALYHRSLPPTINLTELNEEIDFPRTPFVPQLEPAAWQPECGIRRAGITALGGGGYNAHLVLEEPPRPVEREPENRRPRIVTLSALDDAAVSRQRAALSSWLAEHSDARLDDIAYSLNLGRKALPSRWAAVISTRDELLEVLSGDGKSGRVSRFGQERRADLARFRRTEDGLALGSGDEMRDVQALTELAAAWVQGERVNFEVLHADERSHRISLPNYPFARRRFWRTDW	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	143.51	gnl|BL_ORD_ID|1968|hsp_num:0	1943			435	1239	isoniazid
BGC0001041.1|Salinosporamide_10 # 12529 # 14427 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.666	BGC0001041.1|Salinosporamide_10 	12529	14427	-	Loose	1000	115.931	almE	28.37	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACGGCCGCATCGACACTGCACGGCGGCTTTGTCGCCCACGCAGCCGCGAATCCGGACACGCTGGCCGTAGCGTCCGACGCCGGCGTGATGACCTACGGTCGGCTTGACGAGACCTCGGCGGCGCTGGCCGAGCGGCTGTCTGCCTTGGGTGCTGGCCCGGGTGTTCCGATCGGGGTCTGTATCGAACGCACGCCGGACCTGCTCGTCGCTATCCTCGGCGTGCTGCGCGCGGGCGCCTGCTATCTGCCGCTCGATCCTCAATATTCAGCGCGCCACCTCGGCTTCATGGTGGCCGACAGCGGGACCCGCCTGGTCGTTACCACACGATCCTCTCGGGACGCGTGCCCGGACGGCTGCACCGCGCTCGTCCTGGAGGAATCCGAGGCGATAGCCGACCCGCCGCCAGTGGCCGCGGTTCCGGACGATTCTGCCTACGTCATATATACCTCCGGCTCGACCGGCACGCCCAAGGGGGTGCCGATCCGGCACAGCAGCTGCGCGGCGATGCTTGCCGAGGCGGACCGAATTTTCGAGGGCTGTGACATGAGCGGTATCGCCGCCGTCACCTCGGTCTGCTTCGACCTGTCAGTGCTGGAGATCTTCTCCGCCCTCAGCCGTGGCCGGACGCTCGTCCTGGTGAATAGTGCCAGCCACCTTCCGGAGAGCTCCCATGTCGAACGGGTGACGCACGTCAGCACGGTCCCGTCCGCAATGACCAGCCTGCTTGACGCGCAAGCCGTTCCGGCCGGCCTGCGGAACGTGGTGCTCGGCGGCGAACCCGTACGTCGGAGCCTGGTCGACCGGATCTACCGCGAGACCAACGTCGACTTCGTCTTCAACGGATACGGCCCGACGGAAGGCACGGTCTTCTGTACCTTCAAGCCCGTATCCCGCGACGAGGCCGGCGAGCCGTCGATCGGTACGCCATCCCTGACCGCTCGCGTCTATGTGCTCGACGAGAAGCTGCGGCCGTCGGCCGTCGGCGAGTCGGGTGAGCTGTACCTCGGCGGTGCCGGACTTACCTGGGGCTACCTCAACCGGCCCGGGCTGACTGCGGAACGGTTCGTACCTGATCCGCAGGTGGCGGGTGAACGCATGTATCGCACCGGCGACATCGCTCGGCTCAACGAAGCAGGTGAAATCGAGTTCGTGGGACGCTCCGACCTTCAGGTGAAGGTCCGCGGGTACCGCATCGAGCTAGAAGAGGTCGAGGCACGACTGACCGAATGCCCCGAGGTGCGGACGGCTGCGGCCGTCGTCCGTGAGCAGACGCCGGGTACGAGAGCCCTGACCGCGTACGCGGTTCCGGCGAGTGGAGCACCCGACGGCGACGGGCCCTGGCTCGACGCCGACCTGCAGGCAACGATCAAGCAACAGCTCGGTGCGCTGTTGCCCGGTTACATGGTTCCCGAAACGATCGTCTTCCTGCCCGCGCTCCCGCTGTCGCCAGTTGGGAAGCTGGACCGCACGGCGCTACCGGCACCACCCGTTGTCGATGTGCTGCCCTCGGGGGACTCCGCCACCACCGACACCGAACAAGCGCTTGCCGAGATCTGGGGTGCACTGCTGGACCGGACTCCGCAGTCCATCGGCATCCGCGACACATTCTACGACCTCGGCGGCAACTCTTTGTTGTTGGTGCGGCTCGCGAAGCGAATGGGTCAGCGCTTTCACCGCAAGGTCGGCGTGGCGGACCTGTTCCGGTTCCGCGACATCGGCTCGCTCGCCAAGTGGCTGGACGACGAGAGCGGAAAGAGTCCTGAGGACATCGAGCAGGCACGACGCCGTGCCAGCACCAGACGCTCGGTGGTGCGCGGCCACAGCAGATCACCGAGCACTCGAACCGACCCGACCGTCAAGAACACGCCCGCATCAAATGGAGGCCCACATCCATGA	MTAASTLHGGFVAHAAANPDTLAVASDAGVMTYGRLDETSAALAERLSALGAGPGVPIGVCIERTPDLLVAILGVLRAGACYLPLDPQYSARHLGFMVADSGTRLVVTTRSSRDACPDGCTALVLEESEAIADPPPVAAVPDDSAYVIYTSGSTGTPKGVPIRHSSCAAMLAEADRIFEGCDMSGIAAVTSVCFDLSVLEIFSALSRGRTLVLVNSASHLPESSHVERVTHVSTVPSAMTSLLDAQAVPAGLRNVVLGGEPVRRSLVDRIYRETNVDFVFNGYGPTEGTVFCTFKPVSRDEAGEPSIGTPSLTARVYVLDEKLRPSAVGESGELYLGGAGLTWGYLNRPGLTAERFVPDPQVAGERMYRTGDIARLNEAGEIEFVGRSDLQVKVRGYRIELEEVEARLTECPEVRTAAAVVREQTPGTRALTAYAVPASGAPDGDGPWLDADLQATIKQQLGALLPGYMVPETIVFLPALPLSPVGKLDRTALPAPPVVDVLPSGDSATTDTEQALAEIWGALLDRTPQSIGIRDTFYDLGGNSLLLVRLAKRMGQRFHRKVGVADLFRFRDIGSLAKWLDDESGKSPEDIEQARRRASTRRSVVRGHSRSPSTRTDPTVKNTPASNGGPHP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	113.67	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0001041.1|Salinosporamide_12 # 20624 # 20845 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=8bp;gc_cont=0.572	BGC0001041.1|Salinosporamide_12 	20624	20845	-	Loose	500	21.9422	OXA-114e	32.5	3005705	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCAGCCTGGTTCTCTAGGCCGCGGGTGGTTGAACGTTCACAGTCGATCGGTGAGTGTCCGCCGCAGGCCGAGCTTGCCGCCGACCGGCTTTGCCATCAGATTCAGCGCTGTATTGCATCAACAAATTGGGTTTGTTGTTGATGCGAGGGTGCCGAATAGTAGGTACACGTCGAGCTTCGGGAGCCGGAGCAGCGTTCCCACTATCCTCTTGACCGGCTGA	MQPGSLGRGWLNVHSRSVSVRRRPSLPPTGFAIRFSAVLHQQIGFVVDARVPNSRYTSSFGSRSSVPTILLTG	MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAMALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP	26.55	gnl|BL_ORD_ID|3735|hsp_num:0	4805			291	405	cloxacillin; oxacillin; cefalotin
BGC0001041.1|Salinosporamide_13 # 20941 # 21813 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=14bp;gc_cont=0.678	BGC0001041.1|Salinosporamide_13 	20941	21813	+	Loose	920	26.5646	OpmD	55.56	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACGACGACCGGCAGGAGCTTGACATGTCTCGTGAAATGTGGCTACGGTTCGAGATATACCATGATGTGGTATATGCGCCGGAGGCGAGCCTAGTGGCTAAAGAGCTGGGCTGCCGCGGCGGCTGGATGGGCTACTTCGGAACCCGGTCGGCCCCGCTTGGTGCGGCGTCACCCGAGGTGGTGACCGCGGCGTTCTTCAATTTCCACCCGCAGATGGTTGCCAAGGCGGTTCCGCAAGTCTGGTCCGTGGCCTCGCCAGAGCGTTTTCTACAGGCGCGGCTGGAGATCGTCGACGCTGCGCTGCGCCGCATGCTTGGCGCTGATGTGGCCGGGCTCGAGGAGATGGTCACGCTTGCCGCGTCCGCCGCCGCGGGCGTGTCTCCCGGCGGCCGCGTACTGGGTGCTGCCAACCAGGCGCTTCCACCGCCGGTCGAGCCGCATCTCGCGCTCTGGCAGTCCTGCTCGACGCTGCGAGAATCGCGTGGTGACGGCCATGTGGCGGCGCTCGTGGCCGCGGGCCTGGCACCGTGCGAGGCGCTGGTCTTGTTCACGGCCGACAAGGGCCTCGACCCGGCATACATGCGCCGGATGCGCGGATGGTCCGAACAGGAGTGGAAGGAGGCCGAAGCCGCGCTCGTCGATCGTCGTCTGCTCACCGGCGGCGGCCTCACCGTAGCCGGGCGGGAGCTTCGTGCGGAAGTCGAACGGTGGACGGACATGGCAGCGGCGGCCCCGTGGCAGGCTCTGGGAGCCGGTCCCACCGCCAGGCTCCGCGACCTCATGACGCCGGTGGTGCAGCGCCTCAGCGAGCTGAACGAGTCCATGAAGGTAAACCCCATGGCGCTGAATCCGGCGGAGATTGTGGCGTAG	MDDDRQELDMSREMWLRFEIYHDVVYAPEASLVAKELGCRGGWMGYFGTRSAPLGAASPEVVTAAFFNFHPQMVAKAVPQVWSVASPERFLQARLEIVDAALRRMLGADVAGLEEMVTLAASAAAGVSPGGRVLGAANQALPPPVEPHLALWQSCSTLRESRGDGHVAALVAAGLAPCEALVLFTADKGLDPAYMRRMRGWSEQEWKEAEAALVDRRLLTGGGLTVAGRELRAEVERWTDMAAAAPWQALGAGPTARLRDLMTPVVQRLSELNESMKVNPMALNPAEIVA	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	59.55	gnl|BL_ORD_ID|450|hsp_num:0	442			960	1014	acriflavine; tetracycline; norfloxacin
BGC0001041.1|Salinosporamide_15 # 23145 # 23804 # -1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGGGAG;rbs_spacer=8bp;gc_cont=0.662	BGC0001041.1|Salinosporamide_15 	23145	23804	-	Loose	350	26.5646	vanO	33.33	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	GTGGTCAGCGACGTGGACGGTGCCGCACTGGAGAAGTGCCACGCCGAACTGGCCGAGTCCGGAGCCGAGGTGACGACGGTGATCGCCGACGTCTCAGACGCCACCCAGGCACACCGCATGGTTCAGACGGCCGTCGATGTCTACAACCGGCTGGACGTCGTGGTCGCCAACGCTGGCGTGATCCCTCTGCACGAGATCACCGAGGCGACCGAGCAGGACTGGGATGAGGTCATGGCCGTCGATGGCAAGGGCATGTTCCTCACGTGCAAGTACGGCATTGACGCCATGCTGGCCACGGGCGGCTCGATCGTGTGCCTTTCATCTATCTCCGGCGTCGCTGGCCAGCGGGGGCAGAGCACGTACGGCCCGGCCAAGTTCGTGGCTTCCGGGCTCACCAAGCACTTGGCCGTCGAATGCGCACGACACTGCATCCGGGTCAACGCGGTCGCTCCCGGGACTATCCGCACCAACCGGGTCCGCCGGCTCGAAGAAGAACCGGGCGGTCCGGAGTACCTGGAGGACATCGTCCGGCTCCATCCAGCCGGACGCCTGGGCGAGCCGTCGGAGGTGGCAGCCGCGATCGGATTCCTGGCCTCCGACGAGGCCTCGTTCATCACGGGTGTAGTACTTCCCGTCGACGGAGGTTACCTCGCGCAGTGA	MVSDVDGAALEKCHAELAESGAEVTTVIADVSDATQAHRMVQTAVDVYNRLDVVVANAGVIPLHEITEATEQDWDEVMAVDGKGMFLTCKYGIDAMLATGGSIVCLSSISGVAGQRGQSTYGPAKFVASGLTKHLAVECARHCIRVNAVAPGTIRTNRVRRLEEEPGGPEYLEDIVRLHPAGRLGEPSEVAAAIGFLASDEASFITGVVLPVDGGYLAQ	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	63.29	gnl|BL_ORD_ID|1607|hsp_num:0	1754			747	921	vancomycin
BGC0001041.1|Salinosporamide_16 # 24150 # 24929 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=AGGGAG;rbs_spacer=10bp;gc_cont=0.677	BGC0001041.1|Salinosporamide_16 	24150	24929	+	Loose	400	25.409	MAB	48.0	3007180	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	class A Mycobacterium abscessus beta-lactamase	GTGTTTGTACTGTTCATCGGCGACATCGTGGGGGACGAGGGGACACGGTACCTGGTAGACCGGCTGCCCGAACTGCGTGCCCGCCACACGGTGGACCTCGTTGTGGCGAATGCCGAGAACTCGGCGGCCGACGGCTTGGGGATGGGTCGTGTGCAGGTGGAGCAACTGCTGTCCGGAGGGGTTGACGTCATCACCGGCGGAAACCACTCCTGGGACAGCCCAGAGTCGGTCGGGATGCTCAATCTGCCGCAAGTGGTTCGGCCCGCCAACGTGGACCCCGAGGTACCCGGTCGGGGCTTTGTCCATGTCCCGGTCGGCGAGGAGATGGTCACCGTACTGAACCTGGCTGATGGCTGCGCCATGGCGTCGACCAAGGCGACTGCGGGACGGGTGGGTCCCGCCTACTCGGCATGGGAGGCGGCCGACCGGCGCGGCATCACGATCGTCGACTACCACGGCGATCACGTGCTGGAAAAGCAGATCTTCGCCCACACCGTCGACGGCACCGCCGCCGCGGTCGTCGGCACGCACACCCACGAAGCCACCGACCTGCCACGGCTGCTGCCGAACGGCACGGCGTTCGTCACAGAGGTGGGCATGACGGGACCGGACGGCGGCGTGCAGGGTTTCGCTCCCGCAAACCTGGTGAACAACCTGCGGACCACCGGCAACCCGTTCGACGGGCCGATGCCCACGGTGCATCGAGCCCCGATGGTGCTCGGCGCGGTCCTGATCGAGATCGTCGGCGGTCTTGCCGCCGGCATCCAGCGGGTGCGGTGA	MFVLFIGDIVGDEGTRYLVDRLPELRARHTVDLVVANAENSAADGLGMGRVQVEQLLSGGVDVITGGNHSWDSPESVGMLNLPQVVRPANVDPEVPGRGFVHVPVGEEMVTVLNLADGCAMASTKATAGRVGPAYSAWEAADRRGITIVDYHGDHVLEKQIFAHTVDGTAAAVVGTHTHEATDLPRLLPNGTAFVTEVGMTGPDGGVQGFAPANLVNNLRTTGNPFDGPMPTVHRAPMVLGAVLIEIVGGLAAGIQRVR	MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVGHRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTVSELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTSTPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKGETNDIAVIWPPGRAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA	89.62	gnl|BL_ORD_ID|4810|hsp_num:0	5799			495	570	ceftazidime; cefuroxime; amoxicillin; cefalotin; ticarcillin
BGC0001041.1|Salinosporamide_18 # 25764 # 26552 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.660	BGC0001041.1|Salinosporamide_18 	25764	26552	+	Loose	1900	25.0238	MexI	23.94	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGGTCCTCGTCCGCAGGCCGCGGCGACGACGGTCAGGCCACCAGGCTGCTCGTCTCCAGCATCGCGTTCGGGCCGATCAAACCCATCGCCGCGAGCCTGTTGACGGCGGCCACTCGTGAGCGCACATCGAGCTTGTCGTACGTGTTGGTGAGGTGGCGCTTGACCGTGCCCTCGGAGATGGAGAGGCGGCCGGCGATCTGGGCGTTGCTCAGGCCCGCCGCGACCAGCTCGATCACCTCGAACTCCCGGCCCGACAGTGACCGCGTGCCGACCCCGGTCAGATGTTGCAGCATGCTCTTCTGCACGGAAAGCACGGCGCTGTCGCGGTTGCGGCTCACGATCCGTACGACGCTCAGCAGTTCCTCACGCGTCGAGTTCCGCGAGACGTACGCCCACGTACCCATGGCGAGGTACCGGCGCGCCAGGCGCACGTTCTCGTGCATCGCCAGGATTACCAGCCGGGGCTGGCAGGTCGCGGCCAGGATCTGGCCGACCAGCCGCATGATCCCTTGGTCAGACGGGCCGACGCTCAGCAGTACCACGTCTGGCGCCGTCCGTCGAACCAGGGCCGCCGCCATGGGCCCCGCCGCCGCCTGCCCGACCACCCGCAGGTCGGGCTCGCGATCGCAGATCTCGGCCATCGCCTCTCGAAAAATAGTGCTGTCGCCAAGGAGTAGAATCCGTTTCGGACTAGATTCTATGCTGGTCATTAGTCGACTCGATCCGCAATCGGAGTGGCTCTGGTCGAAGCGGCTTCAAGAATGTTTGACACGCCGCCGAAGGTAG	MRSSSAGRGDDGQATRLLVSSIAFGPIKPIAASLLTAATRERTSSLSYVLVRWRLTVPSEMERRPAIWALLRPAATSSITSNSRPDSDRVPTPVRCCSMLFCTESTALSRLRLTIRTTLSSSSRVEFRETYAHVPMARYRRARRTFSCIARITSRGWQVAARIWPTSRMIPWSDGPTLSSTTSGAVRRTRAAAMGPAAACPTTRRSGSRSQISAIASRKIVLSPRSRIRFGLDSMLVISRLDPQSEWLWSKRLQECLTRRRR	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	25.46	gnl|BL_ORD_ID|4683|hsp_num:0	1647			234	447	acriflavine; tetracycline; norfloxacin
BGC0001041.1|Salinosporamide_19 # 26808 # 30308 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.680	BGC0001041.1|Salinosporamide_19 	26808	30308	+	Loose	2000	27.7202	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	42.31	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGGGCTACCTCACCATGATCGGTTCAGACGAATTGCCGAGAAGGAGTCGCATGTCCCCCGGCTTGCAGCCAAGCGAATTCACGTTGGACCAGCGCTATCTGTGCCAGGACGGCACCGCCTACCTCACCGGCGTGCAGGCGCTGGTGCGTCTCCTGCTTGACCGTGTCCGCCACGACCGGCGTGCCGGAAACGACGCGGCGGTCTTCGTCTCCGGCTACGAAGGGTCGCCCCTGGCGGGCTACGACTTGGAGCTCGCCCGCCGGGGCCGACTGCTGGCCGAGCACGGCGTGGTGCATCGGCCCGCACTGAACGAGGAGCTTGCGGCGACGGCCGTGCTCGGCAGCCAGCTCGCTGCGGGCGTCGGCAGACAGCGCCCCGACGGTGTCGTTGGTGTCTGGTACGGCAAGGCGCCGGGTCTCGACCGCGCGGGCGACGCGTTGCGCCACGCGAACTTCGCGGGCACCGACCCGCGGGGCGGTGCCATCGCGCTCGTCGGGGACGATCCAGCGGCGAAGTCGTCGACTGTGCCGAGCGCGTCGGAGTTCGCCCTGGCGGACCTCTCAATGCCGGTCCTCGTGCCAGCAGACGCCGCCGACCTGCTCCGCTACGGCCTGCACGCCATCGAGATGTCCCGGGCGTCCGGCCTATGGTCAGCGCTCAAGATCGTGACCAACGTCGCCGACGCGGCGAGCACGGTGCCGGTCACCCCGTCCTGGCGCTTCCCGACAGTGGCTGGTGGATATCGCCACCGGCCCACGTCCCGGCTGCTCGGCGCGGAACTCGCCGCCTTGGAGGAGAGCCTTCACCGGGTCCGCCTCCCCTTGGCGGTGGAGTATCTGCGCGCCGCCGGCCTGAACGAGCTGTACGGGCACGCGGATGACCGGATCGGGATCGTGGCCGCCGGCAAGTCATATCTGGACGTCCGCCAAGCGCTGCGGACGCTTGGCATGGACGAGGAAGCTCTGCGCCGCTATCGCGTACGGCTACTCAAGCTGGCGGCGGTCTACCCCCTTGAGTCAGCCGTGGTGCGGGAGTTCGCCGCGGGGCTGGACGAGATAGTGGTGGTGGAGGAGAAACGGGGTTTCATCGAATCCGCCGTCAAGGATCTGCTCTATGGCAGCGGCGACGCGCCGGTGGTCTGCGGGAAGACGGATCCGGCGGGGCGGTCGCTGTTCCGCCCCACGGGTGAGCTGAATCCCGACGTGATCGCGGCTGGCCTCGCCCGGCGACTGTCGGCGACCGGCCGCTGCGAACCCGTGGAAGCGTGGCAGGGACGTCGGCGCCGTGACCGCATCGACCTGCCGGTGGTGGCGCGAACCCCATACTTCTGCTCCGGCTGCCCGCACAACTCGTCGACGAAGGCGCCTCCCGGTACCCTGACCGCCGGCGGCACCGGATGTTCCACCATGACCTTCTTCATGGATCCGAAGCGGGTCGGCGACATCATCGGCGTCACGCAGATGGGCGGCGAGGGTGCCCAGTGGATCGGGATGGCACCCTTCGTCGACATCGATCACTTCGTGCAGAACGTAGGCGACGGCACCTTTCACCACTCGGCCAGCCTCGCGCTGCGAGCCGCAGTGGCGGCCGGCGTCAACATTACGTACAAGGTGCTGTACAACTCTGCCGTGGCCATGACCGGTGGTCAGGACGCCGTGGGTGCCTTGCCGGTGCATCGGCTGGCCGCTCTGCTTCTGGCCGAGGGCGCGACCAAGGTGATCGTCACCTCGGAGGATCCAAAGCGGCTCGGCCGGCATCCCATGCCGGCCGGCGTCGAGGTACGCCACCGCGACGATCTGCCGCGCAGCCAGGCGGAACTCGCCGTGACTCCCGGCGTCACCGTGCTCATCCACGACCAGGAGTGCGCGGCGGTACAACGGCGTAAGCGGCGCCGCGGCCTGCGGCCGCAGCCCGCCTACAAAGTGCTGATCAACGAACGGTTGTGCGAGGGATGCGGCGACTGCGGGGCGCAGTCGAACTGCCTGTCGGTCCAGCCGGTAGAAAGCGACTTTGGCCGCAAGACACGTATTCACCAGTCCTCGTGTAACGCCGACTACGCATGCCTACAGGGCCGGTGCCCATCATTCTTGACCATTGTCCCCGGCCGATCCCCGCACCGCGAGCTGGCCTCGGTGCCCACGGCTAAACCATCGATGCCGCGGCAGCGCGTTGTCGGCGACTTCTCAGTGCGGATCACCGGCATCGGCGGCAGCGGCGTGGTAACCCTGGCTCAGATCATCGCCACAGCCGCAGTGCTCGACGGCAGGCACGTGCGGACGCTCGACCAGACCGGGCTGGCCCAGAAGGGCGGTGCGGTCGTCTCCGATGTCCGCGTCACCGAGCGTGCCGTCGAGTCTGCCGCACGGCTAGCGGACGGTGAATGCGATCTCTACCTAGCCACCGACCTGCTCGTCGCGGCTCAGCCCGCCAACCTCGCTGCAGCCGACACCGCCCGGACCGTCGTCGTGGCATCGACCTCGCCGGTGCCCACCGGTCAGATGGTTACCGAGGTGTCGGGCCCACGGCCCGACGTAGACGAACTGTGCTCGGCTCTCGATCGATCGAGTGCGCGCGCCACCTTCTTCGACGCCCGATCCCTCGCCTTGCGCCTGCTGGGTGACGACCAGTTCGCCAATATTCTGCAACTAGGCGCCGCCTACCAGGAGGGCGCCATCCCGCTAGAAGCGGCCAGCATCGAACAGGCGATCCGGCTCAACGGCGTCGGCGTGGAGCGCAACCTCAGCGCCTTCTGCCTCGGCCGCCTGGTGGTTGACGACCCTCAGACGGTGTCGCCGGCAGCTCCCGTAGCCCAGGAGCAACGACCGTTGCAGGGCGATGCAGCATCGTTGCGGGCGACAATCGATGCCGGCGAGGACACCCCACTCGCGCGCCGGCTGGATGCGCTCGTGGCAGATCTCGTCGCCTACCAGGATCTGGCCTATGCCCGCGAGTTTGTGGAGTTCGTGGAACACGTACGCCGGGTGGAGGGACGGGCGGGGCCGCTCACCGCAGCCGTGGCGGGCAATCTATACAAACTTATGGCCTACAAGGATGAGTACGAGGTGGCCCGGCTCTCGCTCGATGAACGCCTGACCCACGACATAGCCGCGCAGTTCGGAGCTGGGGCGCGATACCACTACCTATTGCAGCCACCGGTTCTGAGGAAGCTCGTGCGCCGCAAGATTCGCCTCGGGCAGTGGTTCCGAGTCGTGCTCCGGCTGCTGTACGCACTGCGCAGACTGCGAGGGAGCAGGCTCGATGTCTTCGGCTACACACGCGTGCGCCGGATCGAACGGAGGCTTGTGGCGAACTATCGCAGGACGATCCTCGCCGCGTTGTCGGCGGCCAACCCCGACGACCCGGCGCTGGTAGAGCTGGCGTCTCTGCCAGACATGGTGCGTGGCTTCGACGAGGTCAAGCTCGCCAATGTGACCGAGTACCACCGGCGCCAGGAGCAGTTGCTGCAGTCGCTGCCCCACCCCGTCCAGCAGGTCGGGTAG	MGYLTMIGSDELPRRSRMSPGLQPSEFTLDQRYLCQDGTAYLTGVQALVRLLLDRVRHDRRAGNDAAVFVSGYEGSPLAGYDLELARRGRLLAEHGVVHRPALNEELAATAVLGSQLAAGVGRQRPDGVVGVWYGKAPGLDRAGDALRHANFAGTDPRGGAIALVGDDPAAKSSTVPSASEFALADLSMPVLVPADAADLLRYGLHAIEMSRASGLWSALKIVTNVADAASTVPVTPSWRFPTVAGGYRHRPTSRLLGAELAALEESLHRVRLPLAVEYLRAAGLNELYGHADDRIGIVAAGKSYLDVRQALRTLGMDEEALRRYRVRLLKLAAVYPLESAVVREFAAGLDEIVVVEEKRGFIESAVKDLLYGSGDAPVVCGKTDPAGRSLFRPTGELNPDVIAAGLARRLSATGRCEPVEAWQGRRRRDRIDLPVVARTPYFCSGCPHNSSTKAPPGTLTAGGTGCSTMTFFMDPKRVGDIIGVTQMGGEGAQWIGMAPFVDIDHFVQNVGDGTFHHSASLALRAAVAAGVNITYKVLYNSAVAMTGGQDAVGALPVHRLAALLLAEGATKVIVTSEDPKRLGRHPMPAGVEVRHRDDLPRSQAELAVTPGVTVLIHDQECAAVQRRKRRRGLRPQPAYKVLINERLCEGCGDCGAQSNCLSVQPVESDFGRKTRIHQSSCNADYACLQGRCPSFLTIVPGRSPHRELASVPTAKPSMPRQRVVGDFSVRITGIGGSGVVTLAQIIATAAVLDGRHVRTLDQTGLAQKGGAVVSDVRVTERAVESAARLADGECDLYLATDLLVAAQPANLAAADTARTVVVASTSPVPTGQMVTEVSGPRPDVDELCSALDRSSARATFFDARSLALRLLGDDQFANILQLGAAYQEGAIPLEAASIEQAIRLNGVGVERNLSAFCLGRLVVDDPQTVSPAAPVAQEQRPLQGDAASLRATIDAGEDTPLARRLDALVADLVAYQDLAYAREFVEFVEHVRRVEGRAGPLTAAVAGNLYKLMAYKDEYEVARLSLDERLTHDIAAQFGAGARYHYLLQPPVLRKLVRRKIRLGQWFRVVLRLLYALRRLRGSRLDVFGYTRVRRIERRLVANYRRTILAALSAANPDDPALVELASLPDMVRGFDEVKLANVTEYHRRQEQLLQSLPHPVQQVG	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	98.31	gnl|BL_ORD_ID|4719|hsp_num:0	2914			1830	1908	rifampin
BGC0001041.1|Salinosporamide_20 # 31114 # 31626 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.665	BGC0001041.1|Salinosporamide_20 	31114	31626	-	Loose	700	25.0238	PDC-301	31.43	3006672	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGGCAGCGGTCGTTGCATGGTCCGATCCGCTGGCGCCCGTGGGGCGCGCAACGCTTCGACAGTTGGCCACCCGGCGTCTCCTCGTGGCCGACCTGGACGTTGATCGCCAAGTCGGCCTGGACACCCGGACACGGCTGTTCGCCGACGCCGGCACCCCCACGCCAGAGGTGGTGCTGACATCGAGCATCGCCACGATGCTTGGCCTCGTCGGGGTCGGCGAGGGCTTCGCCCTGCTATACCGGACCGCAGCCAGCCAGTGCTACCGACAGGAACTCGCCTGGATCGACATCGTCTCCGAACGCCCGTGCGCATCCTGGCTTGGTGTGGCGACCATACCCGGCCTGGCTCTCAGCAGCCGTGCGGAGCTATTCGTTTCCCTGCTCGATGACGCTGTCCGGAGCGTCTACTGCACGACGGCGGACGACGGGGTGAGTTCCCCTGGCAGCACTGATATCTTCGATCATGGAGCCTCTTTTGCTACGGACCCCGCCGCACCCGCCTGGTCGACCTAG	MAAVVAWSDPLAPVGRATLRQLATRRLLVADLDVDRQVGLDTRTRLFADAGTPTPEVVLTSSIATMLGLVGVGEGFALLYRTAASQCYRQELAWIDIVSERPCASWLGVATIPGLALSSRAELFVSLLDDAVRSVYCTTADDGVSSPGSTDIFDHGASFATDPAAPAWST	MRDTRFPCLCGIAASTLLFATTPGIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	42.82	gnl|BL_ORD_ID|4362|hsp_num:0	5432			18	228	
BGC0001041.1|Salinosporamide_21 # 33243 # 33698 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGAGGA;rbs_spacer=5bp;gc_cont=0.645	BGC0001041.1|Salinosporamide_21 	33243	33698	-	Loose	260	24.6386	MexG	42.55	3000806	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCACTACGACCACCCTGGCCGGACTGCCCTCGCTGAAGGGATGTGTGCTCGGCCCAAGCTCCTGGAGTGAGATTACGCAGGAGCGCGTCGGCACCTTCGCCGACGCCACCGACGACCACCAGTGGATCCACGTCGATGCCGATCGGGCGGTGAGAGAGAGCCCCTTCGGCGGTCCGATCGGCCACGGCTTCCTGACCCTGTCGTTGATGATCCCAATGTGGAGCGAGATTCTCACCGTCTCGGATGCCGGCATGGTGGTGAACTACGGGCTCAACAGGGTCCGCTTCCCTGCTGCTGTTCCGGTCGGTGCCAAGCTACGCCTGTCCGCCACCCTCGTCGATATCGAACCGGTTAGGGGCGGACTGCAGGTGACGGCCGCCGCCTCGGTTGAACGACAGGGCGACGACAAGCCCGTCTGTGTCGCCGAACCCGTCTTTCGCTTCCTGGGCTGA	MTTTTTLAGLPSLKGCVLGPSSWSEITQERVGTFADATDDHQWIHVDADRAVRESPFGGPIGHGFLTLSLMIPMWSEILTVSDAGMVVNYGLNRVRFPAAVPVGAKLRLSATLVDIEPVRGGLQVTAAASVERQGDDKPVCVAEPVFRFLG	MQRFIDNSLESNWLWLTARICLALMFVASGLAKLFDYQASLEEMRAAGLEPAWLFNIATAVTLLAGSALVLLDRKLWLGAGALAVFLLLTILIVHTFWSKTGVEAKLAMFFALEHIAVIGGLIATAIASAQRQRLRQDVSVAATYQKA	102.03	gnl|BL_ORD_ID|4677|hsp_num:0	995			288	426	acriflavine; tetracycline; norfloxacin
BGC0001041.1|Salinosporamide_23 # 34755 # 35807 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.668	BGC0001041.1|Salinosporamide_23 	34755	35807	-	Loose	700	26.9498	CMA-2	29.76	3006923	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CMA beta-lactamase	ATGGCGATGGCGATAACGTACGGCGGTTCCGTTCCGGTGGTGAAGGTGGCGCGCCTCGCCGGCCAGTACGGGAAGCCCCGATCCTCGGCGACCGATTCCCTGGGGTTGCCCGCGTACCGTGGCGATATTATCAATGCGCGGCACCCGGCCGAGTCGGCGCGGGCCGCCGATCCGCAGCGCATGATCGATGCGTACGCGAATTCCGCGGTCGCGATGAACCTCATCCGCGCCTATCCGCCGGACGATCTGACCGACCTCGAAGAGCTGTACGACGATACCTACGACCTCATCCGCGCTTCCCCGGCCGGAGCCCGGTACCAGGTCATCTCCGGCGAGATCGACCGGGCGCGCGGCTTCGTCCGCGCGTGGGGGCCGAGCGAGCGCCACGCGTTGCGGGAATCAAAGGTGTACTGCTCGCACGAGGCGCTGGTGCTCGAGTACGACCGGGCGCTGACCCGAATCAACGACGGCCGGGCATACGCGTTGTCGGGTCACTTTCTGTGGGTCGGCGAACGCACCCGCCAGCTTGACCACGCGCACGTCGACTTTGTCGCGCGTATCGCCAACCCAATCGGCGTGAAGCTCGGCCCGGCCGCCAGCCCGCATGCTGCGATCGAGCTGTGCGAGCGGCTCAACCCCGAGAACCTGCCCGGGCGGCTCACCCTGATCAGCCGCATGGGCAACCGCCAGGTACGTGACGTGTTTCCGGCGATCGTCGACAAGGTCACGGCCGCGGGCGCCAAGGTCGTTTGGCAGTGCGATCCGATGCACGGCAACACCGAGCAGTCCTCACACGGCTTCAAGACCCGGCGCCTCGACCGGGTCGTTGACGAGTTGCTGGGCTACTTCGACGTGCACCGCAGTCTGGGCACCCATCCGGGAGGCGTCCACGTCGAGCTCACCGGTGAGAACGTCACCGAGTGCCTCGACGGGATACGTGGCGTCGAGGACCAACACCTACCGGATCGCTACGAGACTGCCTGCGACCCGCGGCTGAACATGCGGCAGAGCTTAGAACTCGCGTTGCTGGTCGCCGAGATTCTACGCGGCTGA	MAMAITYGGSVPVVKVARLAGQYGKPRSSATDSLGLPAYRGDIINARHPAESARAADPQRMIDAYANSAVAMNLIRAYPPDDLTDLEELYDDTYDLIRASPAGARYQVISGEIDRARGFVRAWGPSERHALRESKVYCSHEALVLEYDRALTRINDGRAYALSGHFLWVGERTRQLDHAHVDFVARIANPIGVKLGPAASPHAAIELCERLNPENLPGRLTLISRMGNRQVRDVFPAIVDKVTAAGAKVVWQCDPMHGNTEQSSHGFKTRRLDRVVDELLGYFDVHRSLGTHPGGVHVELTGENVTECLDGIRGVEDQHLPDRYETACDPRLNMRQSLELALLVAEILRG	MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVASKATRKPVDEKTLFEIGSLSKTFTATLASAAQQEGKLDFSAPASQYLPALKGSAFDHVTLLNLATHTSGTPLFVPDAVKNTAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALDKPFSEAMEQGLLRDFGMTHTFINVPDAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSGSADLLRYLQIQLGEQEVAPRWRQAINATHNGYYRSGEFTQGMMWEYYPWPSPLSRLVEGNSSQRIMKGLAATAIVPPQPAPEAAWYNKTGSTNGFSSYAVFIPEKRIALIMLANKWFPNDDRVKAAYAIIQQLDK	93.33	gnl|BL_ORD_ID|3393|hsp_num:0	4462			258	495	
BGC0001041.1|Salinosporamide_24 # 36423 # 36722 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGGA;rbs_spacer=8bp;gc_cont=0.630	BGC0001041.1|Salinosporamide_24 	36423	36722	+	Loose	450	25.0238	CfiA18	48.15	3006910	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CfiA beta-lactamase	ATGATCACGCATATCGTACTCTTCAAGCTCAAGGATGGCGTAGACCGCGACGCCCGGCAGGTCACCGAGGCGGTGGAGCTCGCCCGTGAGGTCGGCCGCCACGTACCGGAACTCGTCGACTGGCGCACCGGCTGGAACACGGTCGACCGGGACATCGCCTACGACTTCGCCGCCATTGGCGTGCTGGCTGATCTGGTGGCACTGCAGCGCTACCAGGAAAATGCATTCCACCGAGCCGCCATCGAGAAGTGGAGACTGATATCCGACTGGGTCGTGGCCGACCTGGCTGACCCTGATTGA	MITHIVLFKLKDGVDRDARQVTEAVELAREVGRHVPELVDWRTGWNTVDRDIAYDFAAIGVLADLVALQRYQENAFHRAAIEKWRLISDWVVADLADPD	MKTVFILISMLFPVAVMAQKSVKISNDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYANQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVNQYIESTSKP	39.76	gnl|BL_ORD_ID|3380|hsp_num:0	4449			336	411	
BGC0001041.1|Salinosporamide_25 # 36770 # 38185 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.652	BGC0001041.1|Salinosporamide_25 	36770	38185	+	Loose	400	28.4906	ArnT	48.28	3005053	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGTTCACACAGTACTATCCGGAAGACGCCGCTCTCACAGTCGAGCTGCGTAATCAGGTTGAGGCGTTCATTGCCGGCAAGTGGGACGCGGCGATGCTGGCAGCGCACCAGACCCGCAAGCTGCGTGAGGTCGTTGCTTTTGCCCGCGACAACTCGCCGTTTTACGGGGAGCGCCTGGTCGGGGTGACCGACGAGGTGATCGCGGCCCTGCACCCCGGTAACCTGCGCGACCTCCCGTTCACGACGAAGGATGACCTGCGGCGGGCGCAGTTCGACATGTTGTCGCGGCCGCTCTCCGACGCGTGGATCTTCTACGAAACCACGGGCACCACTGGTGTTGCGACACCGTGTCCACGTACCAATGTGGACTCTTTACACAACAACACCATTCTCACGGCGTACTACCGCGACATTTTCGGCGCGCGTGGCAGCGGCCAGGTCATCGGTATCTCGGGCCCGAGTGAGCTGCACTCTACCGGCGACACCTTCGGCGACGTTTGCCGCAGCCTGGGCCACGCGGTCGCCAAGATGTGGCCACACTCGCCGATGGTCGGCTTCGACCGGGCCCTGGAACTGATGCGTCGGCTACCCGTGACCGGCCTGTTCTGCACGCCCGGCATGGCCATGCACCTGGCACAGCGAGCCATCGACGCCGGGCTGCGGCCGCGGCTGGACTTCTCCCTCGATCTGCTGCTGCTCACCGGCGAGCTGCTCTCGCCTAGTCTGCTGACCAACATCGGCCTGCTCTGGGACGCCGAGGTGCACAACGTGCTCTACGCCTCACAGGAGGCCTCCGTGCTAGCGGCGGCGACTTCGGACGGTCGGCTGCGAACCGCCCCGCTGATCAACCTCTACGAGGTCATCGATCCCGACAGCGGGGAACCGGTCGATTCCGACGGTGCCGGCCAGTGCTACGGCGAGCTCGTGGTCACCAACCTCTACTTGGGCGCCAAGCCTCTCATCAGATACCGCACCGGAGACCTGGTCCGGATGACCGAGTCTGGCGTGTCTGCCGCCGTGCCCGCACCCTCGGTCGAGGTCCTCGGCCGGGCACACGATCGGTTGACGCTCAACGGACACCTCATCAGCGGATATGACTTCGAGAATCTTTTGCTCGGCCAGTTCCGTGGCTTCTGTGACTACCAGGTCACAATCAAGCGCGACGATGCTGGCGTCGATCGAGTCGCTCTGACGCTGCGGTCCGATCCCACCATCGGCTTTCCGAGCGTCGAGGGTGCCGTGCAGCAGTGCCTCGACGAGCTCGACACGCCGCTGACCGTACGGTTCGGCACTCCCGGCGCGATCACCGGGACTGGCGCGATGGTGAGCTGGAAGGCTGCCCGCGTGATCGACCAGCGGACCGGCCAGTCGGACGAGGTCGAAGCGGCCGAGAACATCGCGGCGTCGAGGTCCTGA	MFTQYYPEDAALTVELRNQVEAFIAGKWDAAMLAAHQTRKLREVVAFARDNSPFYGERLVGVTDEVIAALHPGNLRDLPFTTKDDLRRAQFDMLSRPLSDAWIFYETTGTTGVATPCPRTNVDSLHNNTILTAYYRDIFGARGSGQVIGISGPSELHSTGDTFGDVCRSLGHAVAKMWPHSPMVGFDRALELMRRLPVTGLFCTPGMAMHLAQRAIDAGLRPRLDFSLDLLLLTGELLSPSLLTNIGLLWDAEVHNVLYASQEASVLAAATSDGRLRTAPLINLYEVIDPDSGEPVDSDGAGQCYGELVVTNLYLGAKPLIRYRTGDLVRMTESGVSAAVPAPSVEVLGRAHDRLTLNGHLISGYDFENLLLGQFRGFCDYQVTIKRDDAGVDRVALTLRSDPTIGFPSVEGAVQQCLDELDTPLTVRFGTPGAITGTGAMVSWKAARVIDQRTGQSDEVEAAENIAASRS	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	85.48	gnl|BL_ORD_ID|2783|hsp_num:0	3795			246	333	colistin A; colistin B
BGC0001041.1|Salinosporamide_26 # 38185 # 39147 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.675	BGC0001041.1|Salinosporamide_26 	38185	39147	+	Loose	650	28.1054	tetA(58)	32.94	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCGGGCTTGGACCGGGCAGCGTCGCCCGGACTGCGGCTCGGACGCTGGGCCTACCACCGCGGCGAGTTCGTGCCGGCGTCTGATCCGCAGTTGCCGCTCAGCACGCAGGCTTTGCACTATGGGATCGGTGTATTCGAGGGGATTCGGGCGTACCGCAGCGCTGACGGCCTGTTTCTGTTCCGTGCGTACGACCACTACGAGCGCATGCTGCGTGGCTGCCGAACGCTGAGGATTCCGCTGCCGGGGAAGCCCGGCGATCTGGTCGACATCACCGTCGAGCTGCTGCGGCGCAATGCTCACGATGAAGACGTGTACGTGCGGCCGGTGGCCTACAAGCTCTCGTTGCTGCCCGGCATGCCACCTGGCGTATTCCTGAGCGGGCTGTCGGACGCCATGTCGATCATCAGCTACAGCCTGCCGGTTGAGCGGCTCGGCCAGGGCGTGCGGTGTGGCATCAGCTCCTGGCGGCGCCCGCCACGCGACACACTGCCCGCCCAGGCGAAGATCACCGGAGGCTATGTGACGAGCGCTTTCGCTACCGACGAGGCACGAGCAGGCGGGCAGGACGACGCCATCCTGCTTGACCGCTCGGGCAACGTGGCCGAGGCGACAACCGCCAACGTCTTCACGGTCCGCGACGGTTGCCTGGTCACCCCCCCGACAACCGGAGACCTGCTGCCCGGCATTACCAGGGACACGCTCCTCACGCTCATCCGCGAGGTGGGCCTGCCCGTCGCTGAGCGGTCGGTCAGCCCCGCCGAGCTGTTCTCCGCAGACGAGGTTTTCCTCTGTTCCACCGGCAAAGGTGTGGTGCCGGTCATCGCCGTGGCAGGCCGTGACGTCGGCACCGGTGCGATCGGCCCAGTTACCGCCAAGGTCCGTGCGCTCTACGCGGCCGCGACGACCATGCCGGGCGGTATTCACGCGGACTGGCTTACTCCCGTCATGGAGACACCGTGA	MAGLDRAASPGLRLGRWAYHRGEFVPASDPQLPLSTQALHYGIGVFEGIRAYRSADGLFLFRAYDHYERMLRGCRTLRIPLPGKPGDLVDITVELLRRNAHDEDVYVRPVAYKLSLLPGMPPGVFLSGLSDAMSIISYSLPVERLGQGVRCGISSWRRPPRDTLPAQAKITGGYVTSAFATDEARAGGQDDAILLDRSGNVAEATTANVFTVRDGCLVTPPTTGDLLPGITRDTLLTLIREVGLPVAERSVSPAELFSADEVFLCSTGKGVVPVIAVAGRDVGTGAIGPVTAKVRALYAAATTMPGGIHADWLTPVMETP	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	93.29	gnl|BL_ORD_ID|2243|hsp_num:0	2517			744	972	tetracycline
BGC0001041.1|Salinosporamide_27 # 39144 # 39797 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.676	BGC0001041.1|Salinosporamide_27 	39144	39797	+	Loose	525	26.9498	EVM-1	38.46	3006886	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EVM beta-lactamase	GTGACCAAAGCAACGACGTCGTTACCCTGTTTCGTCACCCTCACACCCGCCGCTGCGGGTGGGACGCCGACCGTGGGCACGCTGGGTCCGCCCGGCACGAGCAGCGAGCTGGCCGCGACACTGCTCGCTGGCCGGCTCGGAGCGGCCGATCCCGGGACGGTCGAGGGCGGGCCGACCAGAGTGCGGCTCTTCGATACCTATGAGAGAGCCGGGAGCGCACTGCGCGCGCGCTTGGTGACGCACGTGGTCGTGGCCAACGCCTACAAGGCCGTGCACGAGTTCTACATGGACCCGGATTTCGAGCTGGCCGTGGTGTTCGTTCTGGACACCCCGATGTACGGCATCGCCAAGCGGCGTGGTGCCGGTGCCTCGCCGCCTTCACCCACCATCGCGAGCCACCCGTCACCCGTACCCATCATCGGGCAGTTGCTGAACGGGTCCGGCGCCCACGTGGTGATGCACGCCGACTCGACCAGCTCGGCCGCACTCGCCGCCGCGGAGGGTCGGGTCGACCTGGCGCTCACCACGGCACCCGCCGCGCAGCTGTACGACCTGGAGTTCATCACGCGCACAAGATGCATTCGTATGGTCTGGTCTGCTTTTGTCCTATCGGATCCAGCTCAGGCCACTACGGAGTCAGACGGAGTCGCCTGA	MTKATTSLPCFVTLTPAAAGGTPTVGTLGPPGTSSELAATLLAGRLGAADPGTVEGGPTRVRLFDTYERAGSALRARLVTHVVVANAYKAVHEFYMDPDFELAVVFVLDTPMYGIAKRRGAGASPPSPTIASHPSPVPIIGQLLNGSGAHVVMHADSTSSAALAAAEGRVDLALTTAPAAQLYDLEFITRTRCIRMVWSAFVLSDPAQATTESDGVA	MSVKFLVPIAFALSGCAVLPPPIQTPEPLPPAEEVQPEQWAATCEPWDDWDKPAPPYRIFGSTYYVGTCGISAILIAGDDGHILIDSGTEEGAEVVMDNIQKLGFRLNEIASILHSHEHFDHVGGLAKLRAATGAHIVSSAEAAKVLSTGEDHPEDPQFGVHEPMEPVQVDVIVEDGDTVRTETATVTAHATPGHSPGALSWTWVSCSLPGEPPACSRIAYVDSLSAVSSDDYRFTDHPEVVAAFRTSIDKVRSLPCDILLTPHPSSSQLIERLRTGTLGAPGKCATYAAQLGDKLDERLAKENP	71.15	gnl|BL_ORD_ID|3531|hsp_num:0	4600			759	915	
BGC0001041.1|Salinosporamide_28 # 39811 # 40584 # 1 # ID=1_28;partial=01;start_type=ATG;rbs_motif=AGGGAG;rbs_spacer=7bp;gc_cont=0.690	BGC0001041.1|Salinosporamide_28 	39811	40584	+	Loose	1800	25.7942	mdtC	33.33	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGCTGTTGAGCGGTAAGCAAGTGCTGGAGCTGTATTCGCCGGCCGACGCGTACCAGGTCATCGCGGACGTCATGCGTCGTTACAGCGGCGGCGGCGTCGTGCAGCCGGTGCGTACGGTGCTCAGCTCCGACCGTGACGCGTCACTCTTCGCGTCCATGCCCTGTCATGTTTCCGGCGAGGTCGACTCGGGTTTCGGACTCAAGGCCGTACTTCACGTGCCCGGCAACGCCGAGCGCGGCCTCGTGTCGCATGTGGGTGCCATCCTCGTCTTCCACCCTGACACCGGGCAACCGCTGGCCGTCATCGACGCCGCAGCGGTCACGAGTCTGCGTACGGCCGCAGCTTCGGCCGTAGCAACCGACGCATTGGCCCGCGCGGATGCCGGGGACCTAGCCCTGCTGGGCGCCGGAGTGCAGGCCCGCAGTCACCTGGTGGCCATGAACCGGATCCGGACCCTGCGCCGGGTTCGCGTGTGGAACCGCACTCCCGCCCACGCCGAGCAGTTTCGGGCCTGGGCCCGCTCCCTGGTAGAGGTCGACGTCGAGCTGATGCCGACGCCGGCCGCTGCGCTGCGCGGCGCCGACGTGGTATGCACCACGCTGGGCAGCAGCGATCCGGTGGTCTCCGCAGCCGACATCGCCCCAGGTTGCCACGTTAACGCGGTCGGGGCATCGGTGCCCAGCAAGCGGGAGCTCGACTCGGAGGCGGTCGCGTCGTGTTCTGTCTTCGTCGACAGCCGCGAGGCGGCCATGCGCGAGTCCTCCGAGATC	MLLLSGKQVLELYSPADAYQVIADVMRRYSGGGVVQPVRTVLSSDRDASLFASMPCHVSGEVDSGFGLKAVLHVPGNAERGLVSHVGAILVFHPDTGQPLAVIDAAAVTSLRTAAASAVATDALARADAGDLALLGAGVQARSHLVAMNRIRTLRRVRVWNRTPAHAEQFRAWARSLVEVDVELMPTPAAALRGADVVCTTLGSSDPVVSAADIAPGCHVNAVGASVPSKRELDSEAVASCSVFVDSREAAMRESSEI	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	25.17	gnl|BL_ORD_ID|1212|hsp_num:0	1315			2199	2271	novobiocin
